{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-22-159178","form_type":"8-K","ticker":"SNPS","cik":"0000883241","company_name":"SYNOPSYS INC","filed_at":"2022-05-25T23:59:59+00:00","discovered_at":"2026-05-14T18:04:04.101868+00:00","generated_at":"2026-06-25T07:25:33.527228+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"positive","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Synopsys appoints Luis Borgen and Marc Casper to board, expands from 8 to 10 directors","bullets":["Board expanded from 8 to 10 members; Borgen and Casper appointed as independent directors effective immediately.","Luis Borgen most recently CFO of athenahealth; Marc Casper is chairman, president, and CEO of Thermo Fisher Scientific.","Each new director receives $125,000 annual cash retainer and initial equity grants (stock option $350k FMV, restricted stock $175k prorated).","Board expects to assign each to board committees at a later date; standard indemnification agreements entered.","CEO Aart de Geus cites their operational experience to help scale Synopsys to $5 billion and beyond."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-22-159178","json":"https://secwatch.observer/filing/0001193125-22-159178.json","markdown":"https://secwatch.observer/filing/0001193125-22-159178.md","text":"https://secwatch.observer/filing/0001193125-22-159178.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/883241/000119312522159178/0001193125-22-159178-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/883241/000119312522159178/d356707d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-25T07:25:33.527228+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"99b70c7c99","claim":"Marc Casper was appointed as Director at SYNOPSYS INC.","evidence_excerpt":"the Board of Directors (the “ Board ”) of Synopsys, Inc. (“ Synopsys ”) increased the size of the Board from eight to ten directors and appointed Luis Borgen and Marc Casper (each an “ Appointee ” and together, the “ Appointees ”) to serve as directors effective immediately.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/883241/000119312522159178/0001193125-22-159178-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"a69660c9f6","claim":"Luis Borgen was appointed as Director at SYNOPSYS INC.","evidence_excerpt":"the Board of Directors (the “ Board ”) of Synopsys, Inc. (“ Synopsys ”) increased the size of the Board from eight to ten directors and appointed Luis Borgen and Marc Casper (each an “ Appointee ” and together, the “ Appointees ”) to serve as directors effective immediately.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/883241/000119312522159178/0001193125-22-159178-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}